Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-07-20
    E.g., 2018-07-20

Articles

51281 items
12:00 AM, Feb 09, 2000  |  BC Extra | Company News

ImClone antigen deal with SmithKline

SBH received a license to IMCL's antigens against meningitis, which the pharma company will use to develop a meningitis vaccine. IMCL will receive an upfront fee, plus potential milestones and royalties....
12:00 AM, Feb 09, 2000  |  BC Extra | Company News

Corixa licenses LifeSeq Gold

CRXA will gain access to Incyte's LifeSeq Gold gene database to develop vaccines, therapeutic monoclonal antibodies and diagnostics. INCY could receive milestones and royalties on resulting products. On Tuesday, CRXA announced a collaboration with Genset...
12:00 AM, Feb 09, 2000  |  BC Extra | Company News

Genome Therapeutics and ICAgen deal in ion channels

GENE will use its polymorphism analysis technology to assess and develop clinical trial protocols for an ICAgen ( Research Triangle Park, N.C.) ion channel target. ICAgen's target is associated with the flow of potassium, calcium...
12:00 AM, Feb 09, 2000  |  BC Extra | Company News

MitoKor acquires Chiron Technologies

Mitokor (San Diego, Calif.) acquired Chiron Technologies (Melbourne, Australia), a Chiron (CHIR) subsidiary with expertise in combinatorial chemistry, solid phase synthesis and polymer systems. CHIR will fund specific Chiron Technologies drug discovery projects over the...
12:00 AM, Feb 09, 2000  |  BC Extra | Financial News

Lexicon, Praecis, Exelixis file IPOs

Lexicon (The Woodlands, Texas), which generates knockout mice, filed to raise up to $100 million. The offering will be underwritten by J.P. Morgan; Credit Suisse First Boston; Dain Rauscher Wessels; and Punk Ziegel. Praecis (...
12:00 AM, Feb 08, 2000  |  BC Extra | Financial News

deCode pondering IPO

deCode Genetics (Reykjavik, Iceland) apparently is exploring the idea of selling an IPO on NASDAQ, on the heels of receiving a government license to create and operate a national medical and genetic database for Iceland...
12:00 AM, Feb 08, 2000  |  BC Extra | Financial News

Adolor files for IPO

Adolor (Malvern, Penn.), which is developing therapeutics to treat pain, filed to raise $72-$84 million through the sale of 6 million shares at $12-$14 per share. The IPO will be underwritten by Warburg Dillon Read;...
12:00 AM, Feb 08, 2000  |  BC Extra | Financial News

Martek raises $10.25 million

MATK raised $10.25 million through the sale of 845,652 shares at $12.12 per share. Investors also received three-year warrants to purchase 253,695 MATK shares at $14.55. The company previously raised $10.25 million in a 1998...
12:00 AM, Feb 08, 2000  |  BC Extra | Company News

Alkermes hGH deal with Lilly

ALKS will use its AIR pulmonary drug delivery technology to develop an inhaled formulation of human growth hormone (hGH) for LLY. ALKS will receive upfront fees, research funding and milestones, and is eligible for royalties....
12:00 AM, Feb 08, 2000  |  BC Extra | Financial News

Tuesday market watch

A good day for biotech issues pushed the BioCentury 100 up 4.3 percent to 2998.26, with advancing issues outpacing decliners 67 to 25. Tuesday's movers included genome mapper CuraGen (CRGN), which popped $34.125 (38 percent)...

Pages